Developer docs
API playgroundTry for free, no card

Search company profiles

Vestagen Technical Textiles

Full company profile

uuid0003jk2

Namestring
Vestagen Technical Textiles
Websiteurl
vestagen.com
Company typeenum
Private
Founded yearint
2009
Short descriptiontext

Vestagen Technical Textiles develops, manufactures, and markets textile products and technologies for the healthcare sector. Founded in 2009 in Orlando, Florida, the company has raised approximately $36 million from venture and health-system investors to commercialize antimicrobial healthcare textile offerings.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOrlando, United States
HQ citystring
Orlando
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
antimicrobial medical textiles, healthcare protective fabrics, infection control apparel, hospital textile products, pathogen resistant uniforms
Industry3 codes
PRIMARYIMAOADAD
Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)
SECONDARYIMAOABAH
Technical Fabric Mills (Performance/Protective/Medical Substrates)
SECONDARYIMAOADAA
Protective & Safety Textiles (FR/Arc/Heat/Cut/Chemical)
NAICS code2 codes
  • Textile and Fabric Finishing and Fabric Coating Mills3133
  • Fabric Coating Mills31332
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Antimicrobial Healthcare Textiles
Cost components5 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Vestagen Technical Textiles develops, manufactures, and markets textile products and technologies for healthcare settings. The company's portfolio centers on antimicrobial and fluid-resistant fabric technologies intended for healthcare worker uniforms, scrubs, lab coats, and patient apparel, addressing pathogen transmission risks in clinical environments.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Antimicrobial Healthcare Textile Products
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Peers10 records
TypeDirect peer
Description

LifeThreads manufactures antimicrobial-finished medical scrubs, lab coats, and patient apparel for hospitals. It competes with Vestagen on the same antimicrobial medical-apparel use case and customer base.

TypeDirect peer
Description

PurThread embeds antimicrobial agents directly into textile fibers for healthcare apparel and linens — the closest direct competitor to Vestagen's VESTEX-style antimicrobial medical textile platform, targeting the same hospital infection-prevention buyer.

TypeDirect peer
Description

Applied Silver develops silver-ion based antimicrobial textile treatments (SilvaClean) for healthcare linens and apparel. It is a direct competitor in the antimicrobial hospital textile category with comparable clinical-evidence positioning.

TypeDirect peer
Description

Noble Biomaterials makes X-STATIC silver-based antimicrobial textiles used in healthcare, defense, and performance apparel. It is a direct peer with a more established IP portfolio and broader customer base in antimicrobial technical textiles.

TypeDirect peer
Description

HeiQ develops antimicrobial and hygiene textile technologies (e.g., HeiQ Viroblock) used in medical and consumer applications. It is a direct competitor in the antimicrobial textile chemistry space with broader global scale.

6Medline Industries
TypeBroad incumbent
Description

Medline is one of the largest manufacturers and distributors of medical apparel, gowns, and reusable textiles in the U.S. It serves as a broad incumbent competitor that any antimicrobial textile challenger must displace in hospital procurement contracts.

TypeBroad incumbent
Description

Standard Textile manufactures and launders reusable healthcare textiles including gowns, linens, and barrier fabrics. It overlaps with Vestagen on the medical-textile product side and on hospital laundering/distribution economics.

TypeEmerging player
Description

Cupron embeds copper-oxide based antimicrobial technology into textiles for healthcare, institutional, and consumer use. It is an emerging peer with comparable antimicrobial textile chemistry but a different go-to-market focus.

TypeEmerging player
Description

BioCote licenses antimicrobial additives and coatings to textile and surface manufacturers. It is an emerging technology peer that competes at the chemistry/coating layer beneath finished antimicrobial textiles like Vestagen's products.

TypeBroad incumbent
Description

Cardinal Health distributes medical apparel, gowns, and infection-prevention products at scale through its U.S. hospital network. It functions as a broad incumbent competitor and potential channel partner in the hospital textile category.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vestagen Technical Textiles

Antimicrobial Healthcare Textilesvestagen.com

Vestagen Technical Textiles develops, manufactures, and markets textile products and technologies for the healthcare sector. Founded in 2009 in Orlando, Florida, the company has raised approximately $36 million from venture and health-system investors to commercialize antimicrobial healthcare textile offerings.

Vestagen Technical Textiles firmographics

Firmographics
Name
Vestagen Technical Textiles
Website
https://vestagen.com
Company type
Private
Founded year
2009
Headcount range
11–50 employees
Short description
Vestagen Technical Textiles develops, manufactures, and markets textile products and technologies for the healthcare sector. Founded in 2009 in Orlando, Florida, the company has raised approximately $36 million from venture and health-system investors to commercialize antimicrobial healthcare textile offerings.
Ownership category
akta.pro rank

Vestagen Technical Textiles industry classification

Industry
Product category
Antimicrobial Healthcare Textiles
NAICS
Textile and Fabric Finishing and Fabric Coating Mills (3133), Fabric Coating Mills (31332)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYIMAOADAD
Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)
SECONDARYIMAOABAH
Technical Fabric Mills (Performance/Protective/Medical Substrates)
SECONDARYIMAOADAA
Protective & Safety Textiles (FR/Arc/Heat/Cut/Chemical)

Keywords

  • Antimicrobial medical textiles
  • Healthcare protective fabrics
  • Infection control apparel
  • Hospital textile products
  • Pathogen resistant uniforms

Where Vestagen Technical Textiles is headquartered

Location

Headquarters

HQ city
Orlando
HQ country
United States
HQ region
North America

Markets served

Vestagen Technical Textiles business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Vestagen Technical Textiles product offering

Product offering

Core offering

Vestagen Technical Textiles develops, manufactures, and markets textile products and technologies for healthcare settings. The company's portfolio centers on antimicrobial and fluid-resistant fabric technologies intended for healthcare worker uniforms, scrubs, lab coats, and patient apparel, addressing pathogen transmission risks in clinical environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antimicrobial Healthcare Textile Products

Companies that use Vestagen Technical Textiles

Customer profile

Ideal customer profiles1 record

Vestagen Technical Textiles technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Vestagen Technical Textiles partnerships and signals

Strategic signal

Scale indicators2 records

Vestagen Technical Textiles competitors and assessment

Company assessment

Direct peers

  • LifeThreads: LifeThreads manufactures antimicrobial-finished medical scrubs, lab coats, and patient apparel for hospitals. It competes with Vestagen on the same antimicrobial medical-apparel use case and customer base.
  • PurThread Technologies: PurThread embeds antimicrobial agents directly into textile fibers for healthcare apparel and linens — the closest direct competitor to Vestagen's VESTEX-style antimicrobial medical textile platform, targeting the same hospital infection-prevention buyer.
  • Applied Silver: Applied Silver develops silver-ion based antimicrobial textile treatments (SilvaClean) for healthcare linens and apparel. It is a direct competitor in the antimicrobial hospital textile category with comparable clinical-evidence positioning.
  • Noble Biomaterials: Noble Biomaterials makes X-STATIC silver-based antimicrobial textiles used in healthcare, defense, and performance apparel. It is a direct peer with a more established IP portfolio and broader customer base in antimicrobial technical textiles.
  • HeiQ Materials: HeiQ develops antimicrobial and hygiene textile technologies (e.g., HeiQ Viroblock) used in medical and consumer applications. It is a direct competitor in the antimicrobial textile chemistry space with broader global scale.

Broad incumbents

  • Medline Industries: Medline is one of the largest manufacturers and distributors of medical apparel, gowns, and reusable textiles in the U.S. It serves as a broad incumbent competitor that any antimicrobial textile challenger must displace in hospital procurement contracts.
  • Standard Textile: Standard Textile manufactures and launders reusable healthcare textiles including gowns, linens, and barrier fabrics. It overlaps with Vestagen on the medical-textile product side and on hospital laundering/distribution economics.
  • Cardinal Health: Cardinal Health distributes medical apparel, gowns, and infection-prevention products at scale through its U.S. hospital network. It functions as a broad incumbent competitor and potential channel partner in the hospital textile category.

Emerging players

  • Cupron: Cupron embeds copper-oxide based antimicrobial technology into textiles for healthcare, institutional, and consumer use. It is an emerging peer with comparable antimicrobial textile chemistry but a different go-to-market focus.
  • BioCote: BioCote licenses antimicrobial additives and coatings to textile and surface manufacturers. It is an emerging technology peer that competes at the chemistry/coating layer beneath finished antimicrobial textiles like Vestagen's products.

Market position

Customer concentration

Vestagen Technical Textiles social profiles

Digital presence

Vestagen Technical Textiles financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vestagen Technical Textiles leadership team

Management profile

Number of profiles

Profiles3 records

Vestagen Technical Textiles funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vestagen Technical Textiles M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vestagen Technical Textiles

What does Vestagen Technical Textiles do?

Vestagen Technical Textiles develops, manufactures, and markets textile products and technologies for healthcare settings. The company's portfolio centers on antimicrobial and fluid-resistant fabric technologies intended for healthcare worker uniforms, scrubs, lab coats, and patient apparel, addressing pathogen transmission risks in clinical environments.

When was Vestagen Technical Textiles founded?

Vestagen Technical Textiles was founded in 2009. It employs 11 to 50 people.

Where is Vestagen Technical Textiles based?

Vestagen Technical Textiles is headquartered in Orlando, United States, in the North America region.

Who are Vestagen Technical Textiles's main competitors?

Direct peers on record are LifeThreads, PurThread Technologies, Applied Silver, Noble Biomaterials and HeiQ Materials. Broad incumbents are Medline Industries, Standard Textile and Cardinal Health. Emerging players are Cupron and BioCote.

Does Vestagen Technical Textiles have an API?

No public API is recorded for Vestagen Technical Textiles.

What industry is Vestagen Technical Textiles in?

Vestagen Technical Textiles's product category is Antimicrobial Healthcare Textiles. Its primary akta.pro industry code is IMAOADAD, Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics), with a secondary code of IMAOABAH, Technical Fabric Mills (Performance/Protective/Medical Substrates). Its NAICS code is 3133 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireVESTEX® Active Barrier Healthcare Scrubs First-Ever to Receive FDA Designation as Class II Medical DeviceVestagen Protective Technologies announced that its VESTEX healthcare scrubs received FDA 510(k) clearance as a Class II medical device, the first daily-wear scrubs to do so. The clearance is based on studies showing fluid repellency and reduced MRSA retention on the fabric surface. The company plans to seek strategic partners to extend the technology to other high-risk work sectors.PR NewswireNew Data Shows Vestagen's VESTEX® Repels Fluids and Reduces Pathogen Bioburden on the Fabric by More than 99% Compared to Conventional ScrubsVestagen Protective Technologies announced on December 6, 2017 that two independent laboratory studies on its VESTEX Active Barrier fabric will be presented at the Institute for Healthcare Improvement 2017 National Forum in Orlando. The studies found VESTEX repelled all tested simulated body fluids and hazardous drugs, and reduced bioburden of multi-drug resistant organisms by more than 99% compared with conventional scrubs.FinSMEsVestagen Protective Technologies Closes $9.5m FinancingVestagen Protective Technologies closed a $9.5 million financing round with backers including Advent Life Sciences, HealthQuest Capital, and new investors. The company will use the funds to generate clinical evidence of its protective fabrics, obtain regulatory review, and expand commercialization.PR NewswireVestagen Wins Baseless Lawsuit Brought by Large CompetitorJurors in a U.S. federal court in California ruled in favor of Vestagen Protective Technologies, rejecting all allegations from competitor Strategic Partners, Inc. The verdict came after a week-long trial on a 2016 lawsuit claiming false advertising. Vestagen's CEO called it a victory for entrepreneurial companies.PR NewswireStandard Textile and Vestagen Establish Strategic Partnership for VESTEX® Apparel for Healthcare WorkersStandard Textile Co., Inc. and Vestagen Protective Technologies, Inc. announced on August 15, 2017 a strategic partnership to co-exclusively market VESTEX® Active Barrier garments to healthcare workers across the U.S. and Canada. Standard Textile's healthcare sales representatives will sell the garments, which repel body fluids and contain an EPA-registered antimicrobial agent, while Vestagen will support implementation with institutional customers. The partnership is described as potentially transformational for Vestagen, giving it expanded distribution reach through Standard Textile's established network.PR NewswireVestagen Cites New Peer-Reviewed Article Supporting Use of Healthcare Worker Uniforms that May Minimize the Risks of Unexpected Fluid ExposuresVestagen Protective Technologies announced the publication of a peer-reviewed commentary co-authored with The Leapfrog Group, which advocates for the widespread use of active barrier uniforms to reduce unexpected fluid exposures in healthcare settings. The article highlights that approximately 80% of such exposures are unanticipated and emphasizes the safety benefits of Vestagen's VESTEX fabric technology over traditional personal protective equipment.FinSMEsVestagen Holds First Closing of $10M FinancingVestagen Protective Technologies held its first close of a $10M financing, with backers including Advent Life Sciences, HealthQuest Capital, and new investor Northwell Ventures. The company will use proceeds for general corporate purposes and increased commercialization of its VESTEX active barrier fabric scrubs, lab coats, and patient garments.PR NewswireVetDriven Licenses Rights to Vestagen's Active Barrier Fabric for Veterinary and Pet Markets and Launches VESTEX® Scrubs for VeterinariansVetDriven, Inc. has secured exclusive rights from Vestagen Protective Technologies, Inc. to manufacture and distribute VESTEX® active barrier fabric products for the veterinary and consumer pet markets in the U.S. Concurrently, VetDriven launched its VESTEX Active Barrier uniforms for veterinarians and announced the completion of a seed financing round from private investors.FinSMEsVestagen Technical Textiles Completes $7M FinancingVestagen Technical Textiles completed a $7M financing, with backers including Advent Life Sciences and HealthQuest Capital. The funds will commercialize its VESTEX active barrier protective technology, which combines fluid repellent, antimicrobial, and breathability properties for healthcare and other applications.VC News DailyVestagen Completes $7M FinancingVestagen Technical Textiles, a medical technology company, has completed a $7.0 million financing round led by Advent Life Sciences and HealthQuest Capital, with participation from existing investors. The company also appointed Bill Bold as Chief Executive Officer, succeeding Dale Pfost who remains as Chairman. Proceeds from the financing will support commercialization of VESTEX, the company's active barrier technology combining fluid repellent, antimicrobial and breathability properties, including expansion of its product line and FDA review filing.